Ensuring Access to Lower-Cost Medicines for Seniors Act
Introduced Apr 16, 2026 by Sen. James Lankford
It's waiting on a committee vote to reach the full chamber. Most bills never leave this stage.
This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies.
Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.
Summary by the Congressional Research Service.
No floor votes yet — it hasn't reached the floor of either chamber.